Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2019

01-02-2019 | Urologic Oncology

Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma

Authors: Hau-Chern Jan, MD, Wen-Horng Yang, MD, Chien-Hui Ou, MD

Published in: Annals of Surgical Oncology | Issue 2/2019

Login to get access

Abstract

Background

This study aimed to evaluate the clinical significance of the preoperative systemic immune-inflammation index (SII) combined with the monocyte-lymphocyte ratio (MLR) for patients with upper-tract urothelial carcinoma (UTUC).

Methods

The clinical data of 424 patients who underwent radical nephroureterectomy from January 2007 to June 2017 were analyzed. Kaplan–Meier analyses and Cox proportional hazards models were used to evaluate associations of preoperative systemic immune-inflammatory biomarkers with overall survival (OS), cancer-specific survival (CSS), and progression-free survival (PFS). Moreover, logistic regression preoperative models were applied to predict advanced disease.

Results

Multivariate analyses showed that SII significantly influenced both OS and CSS (both P < 0.05), whereas MLR exhibited the most significant association with OS (P = 0.008). In particular, simultaneously high SII and MLR values correlated significantly with OS, CSS, and PFS (all P < 0.05). Logistic regression preoperative models showed that the combination of high SII and high MLR was a significant predictor of non-organ-confined UTUC (P = 0.001). Furthermore, Kaplan–Meier analysis showed that the combination of high SII and high MLR was significantly linked with poor OS, CSS, and PFS in non-organ-confined UTUC (all P < 0.05).

Conclusion

The study reviewed serum inflammation biomarkers in a subset of patients with UTUC and demonstrated the ability of combined SII and MLR to predict disease progression and survival. Patients with both high SII and high MLR were significantly more likely to have non-organ-confined disease and poor survival outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int. 2011;107:1059–64.CrossRefPubMed Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005. BJU Int. 2011;107:1059–64.CrossRefPubMed
2.
go back to reference Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85:1342–4.CrossRefPubMed Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85:1342–4.CrossRefPubMed
3.
go back to reference Yang MH, Chen KK, Yen CC, et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology. 2002;59:681–7.CrossRefPubMed Yang MH, Chen KK, Yen CC, et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology. 2002;59:681–7.CrossRefPubMed
4.
go back to reference Margulis V, Youssef RF, Karakiewicz PI, et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010;184:453–8.CrossRefPubMed Margulis V, Youssef RF, Karakiewicz PI, et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010;184:453–8.CrossRefPubMed
5.
go back to reference Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.CrossRefPubMed Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.CrossRefPubMed
6.
go back to reference Chromecki TF, Bensalah K, Remzi M, et al. Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol. 2011;8:440–7.CrossRefPubMed Chromecki TF, Bensalah K, Remzi M, et al. Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol. 2011;8:440–7.CrossRefPubMed
7.
go back to reference Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62:100–14.CrossRefPubMed Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62:100–14.CrossRefPubMed
8.
go back to reference Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212–22.CrossRefPubMed Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212–22.CrossRefPubMed
9.
go back to reference Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil-lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014;12:58.CrossRefPubMedPubMedCentral Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil-lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014;12:58.CrossRefPubMedPubMedCentral
10.
go back to reference Hu H, Yao X, Xie X, et al. Prognostic value of preoperative NLR, dNLR, PLR, and CRP in surgical renal cell carcinoma patients. World J Urol. 2017;35:261–70.CrossRefPubMed Hu H, Yao X, Xie X, et al. Prognostic value of preoperative NLR, dNLR, PLR, and CRP in surgical renal cell carcinoma patients. World J Urol. 2017;35:261–70.CrossRefPubMed
11.
go back to reference Ying HQ, Deng QW, He BS, et al. The prognostic value of preoperative NLR, d-NLR, PLR, and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31:305.CrossRefPubMed Ying HQ, Deng QW, He BS, et al. The prognostic value of preoperative NLR, d-NLR, PLR, and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31:305.CrossRefPubMed
12.
go back to reference Altan M, Haberal HB, Akdogan B, Ozen H. A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma. Int J Clin Oncol. 2017;22:964–71.CrossRefPubMed Altan M, Haberal HB, Akdogan B, Ozen H. A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma. Int J Clin Oncol. 2017;22:964–71.CrossRefPubMed
13.
go back to reference Azuma T, Matayoshi Y, Odani K, et al. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer. 2013;11:337–41.CrossRefPubMed Azuma T, Matayoshi Y, Odani K, et al. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer. 2013;11:337–41.CrossRefPubMed
14.
go back to reference Dalpiaz O, Ehrlich GC, Mannweiler S, et al. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int. 2014;114:334–9.PubMed Dalpiaz O, Ehrlich GC, Mannweiler S, et al. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int. 2014;114:334–9.PubMed
15.
go back to reference Luo HL, Chen YT, Chuang YC, et al. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome. BJU Int. 2014;113:E144–9.CrossRefPubMed Luo HL, Chen YT, Chuang YC, et al. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome. BJU Int. 2014;113:E144–9.CrossRefPubMed
16.
go back to reference Tanaka N, Kikuchi E, Kanao K, et al. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper-tract urothelial carcinoma treated with radical nephroureterectomy. Ann Surg Oncol. 2014;21:4041–8.CrossRefPubMed Tanaka N, Kikuchi E, Kanao K, et al. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper-tract urothelial carcinoma treated with radical nephroureterectomy. Ann Surg Oncol. 2014;21:4041–8.CrossRefPubMed
17.
go back to reference Dalpiaz O, Krieger D, Ehrlich GC, et al. Validation of the Preoperative platelet-to-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper-tract urothelial carcinoma. Urol Int. 2017;98:320–7.CrossRefPubMed Dalpiaz O, Krieger D, Ehrlich GC, et al. Validation of the Preoperative platelet-to-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper-tract urothelial carcinoma. Urol Int. 2017;98:320–7.CrossRefPubMed
18.
go back to reference Hutterer GC, Sobolev N, Ehrlich GC, et al. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper-tract urothelial carcinoma. J Clin Pathol. 2015;68:351–5.CrossRefPubMed Hutterer GC, Sobolev N, Ehrlich GC, et al. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper-tract urothelial carcinoma. J Clin Pathol. 2015;68:351–5.CrossRefPubMed
19.
go back to reference Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine Baltimore. 2017;96:e5886.CrossRefPubMedPubMedCentral Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine Baltimore. 2017;96:e5886.CrossRefPubMedPubMedCentral
20.
go back to reference Wang L, Wang C, Wang J, Huang X, Cheng Y. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143:2077–86.CrossRefPubMed Wang L, Wang C, Wang J, Huang X, Cheng Y. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143:2077–86.CrossRefPubMed
21.
go back to reference Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017;15:221.CrossRefPubMedPubMedCentral Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017;15:221.CrossRefPubMedPubMedCentral
22.
go back to reference Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236:297–304.CrossRefPubMed Hong X, Cui B, Wang M, Yang Z, Wang L, Xu Q. Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer. Tohoku J Exp Med. 2015;236:297–304.CrossRefPubMed
23.
go back to reference Huang L, Liu S, Lei Y, et al. Systemic immune-inflammation index, thymidine phosphorylase, and survival of localized gastric cancer patients after curative resection. Oncotarget. 2016;7:44185–93.PubMedPubMedCentral Huang L, Liu S, Lei Y, et al. Systemic immune-inflammation index, thymidine phosphorylase, and survival of localized gastric cancer patients after curative resection. Oncotarget. 2016;7:44185–93.PubMedPubMedCentral
24.
25.
go back to reference Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23:6261–72.CrossRefPubMedPubMedCentral Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23:6261–72.CrossRefPubMedPubMedCentral
26.
go back to reference Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study. Ann Surg. 2018. https://doi.org/10.1097/SLA.0000000000002660 Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort study. Ann Surg. 2018. https://​doi.​org/​10.​1097/​SLA.​0000000000002660​
27.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.
30.
go back to reference Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.CrossRefPubMed Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.CrossRefPubMed
31.
go back to reference Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28:187–96.CrossRefPubMed Moses K, Brandau S. Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol. 2016;28:187–96.CrossRefPubMed
32.
go back to reference Placke T, Kopp HG, Salih HR. The wolf in sheep’s clothing: platelet-derived “pseudo self” impairs cancer cell “missing self” recognition by NK cells. Oncoimmunology. 2012;1:557–9.CrossRefPubMedPubMedCentral Placke T, Kopp HG, Salih HR. The wolf in sheep’s clothing: platelet-derived “pseudo self” impairs cancer cell “missing self” recognition by NK cells. Oncoimmunology. 2012;1:557–9.CrossRefPubMedPubMedCentral
33.
go back to reference Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576–90.CrossRefPubMedPubMedCentral Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576–90.CrossRefPubMedPubMedCentral
34.
go back to reference Lavergne M, Janus-Bell E, Schaff M, Gachet C, Mangin PH. Platelet integrins in tumor metastasis: do they represent a therapeutic target? Cancers Basel. 2017;9(10):133–50.CrossRefPubMedCentral Lavergne M, Janus-Bell E, Schaff M, Gachet C, Mangin PH. Platelet integrins in tumor metastasis: do they represent a therapeutic target? Cancers Basel. 2017;9(10):133–50.CrossRefPubMedCentral
35.
go back to reference Hamilton G, Rath B, Klameth L, Hochmair MJ. Small cell lung cancer: recruitment of macrophages by circulating tumor cells. Oncoimmunology. 2016;5:e1093277.CrossRefPubMed Hamilton G, Rath B, Klameth L, Hochmair MJ. Small cell lung cancer: recruitment of macrophages by circulating tumor cells. Oncoimmunology. 2016;5:e1093277.CrossRefPubMed
36.
go back to reference Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147.PubMedPubMedCentral Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147.PubMedPubMedCentral
Metadata
Title
Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma
Authors
Hau-Chern Jan, MD
Wen-Horng Yang, MD
Chien-Hui Ou, MD
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6942-3

Other articles of this Issue 2/2019

Annals of Surgical Oncology 2/2019 Go to the issue